Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_assertion type Assertion NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_head.
- NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_assertion description "[These data suggest that the transcriptionally targeted hALA or oBLG driven expression of the HSVtk gene may be a feasible therapy for the treatment of human breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_provenance.
- NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_assertion evidence source_evidence_literature NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_provenance.
- NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_assertion SIO_000772 10505111 NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_provenance.
- NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_assertion wasDerivedFrom befree-20140225 NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_provenance.
- NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_assertion wasGeneratedBy ECO_0000203 NP691096.RACUYIJUZOeFuEGxEqwQxoxlrljmrgwVHXdqti3y6Xvxw130_provenance.